SDT fa/faラットのセメントとアルベオラ骨のヒト内化学的評価 II型糖尿病

Tomoka Hasegawa¹, Mako Sakakibara¹, Xuanyu Liu¹

¹Ultrastructure of Hard Tissues, Faculty of Dental Medicine, Hokkaido University, Sapporo, Japan.

Oral diseases

|September 1, 2025

まとめ

糖尿病のラット (SDT fa / fa) は,骨の損失と死んだセメントの細菌巣を伴う重度の歯周炎を示しました. これは2型糖尿病が歯周病組織に与える影響を強調しています

科学分野:

口腔生物学
糖尿病について
歯周病学

背景:

2型糖尿病は歯周病のリスクと重症度の上昇と関連しています.
糖尿病の歯周病組織における特定の組織病理学的変化を理解することは,標的治療の開発に不可欠です.

研究の目的:

2型糖尿病のラットモデルにおける歯周組織のヒト病理学的特性を調査する (トーリ・レッパー法,SDT fa/fa).
糖尿病と歯周組織の変化の関係を解明する.

主な方法:

30週齢のSDT fa/faマウスと年齢相応のSprague-Dawley (SD) マウスの歯周組織をヒト内化学的に検査する.
分析は下第一歯と関連する歯周構造に焦点を当てた.

主要な成果:

SDT fa/faラットは上皮の成長低下,高アルベオラ骨の周回 (骨格結晶と骨格結晶の増加),および死滅した歯のパルプとセメントの細菌の存在を示した.
糖尿病のラットにおけるセメントは,マトリックスタンパク質 (オステオカルシン,オステオポントン,DMP- 1) の免疫局所化が変化したが,関連する血管と繊維組織で発見された高度なグリケーション末端産物が欠けていた.
シメント細胞の空白は細胞死を示唆した

結論:

SDT fa/ faネズミは,刺激された再吸収と形成により,歯のパルプの死滅と重要なアルベオラ骨の損失を特徴とする重度の歯周炎を発症した.
死んだセメントはバクテリアの貯蔵庫として作用し,セメントマトリックスタンパク質の局所化と歯周病の破壊に寄与する.

キーワード:

SDT fa/fa ラットアルベオラ骨シメント糖尿病歯周病

さらに関連する動画

06:16

Author Spotlight: Establishing an Accurate Microhardness Testing Protocol for Craniofacial Tissues

Published on: April 26, 2024

826

02:08

Surgical Bone Implantation Technique for Rat Tibia Models of Diabetes and Osteoporosis

Published on: July 5, 2024

874

関連する概念動画

01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

関連する実験動画